Meet our project team

FT3 Board

The Board leads the program, defining the long and medium-term objectives while respecting internal FT3 principles and rules. It represents the interests of members. The role of the FT3 Board member is voluntary and is not compensated for.

Find out more about the FT3 Governance structure.

Bahija Gouimi

President & Founder, AMAL Morocco

Barry Stein

President & CEO
Colorectal Cancer Canada

Dr. Charles Alessi

Independent Expert

Dr. Durhane Wong-Rieger

President, CORD

Ivica Belina

President, Koalicija udruga u zdravstvu (KUZ)

James Creeden

Independent Expert

Jeanie Hsieh

Global Director, Precision Medicine Patient Programs & Pharma Consortia MSD Innovation & Development GmbH

Lee-Anne Zinetti
Senior

Director of Global Precision Diagnostics
Novartis

Nicole Sheahan

President, Global Colon Cancer Association

Petra ADÁMKOVÁ

Director, Cancer Patients Voice, Chair, ENGAGe, Co-chair

Dr. Pooja Merchant

Head Patient Partnerships and Engagement Oncology, Bayer

Dr. Razelle Kurzrock

Independent expert

Runcie C.W. Chidebe

Executive Director, Project PinkBlue

Ralph Riley

Global Co-Diagnostics Market Access Leader, Janssen

Susan McClure

Patient Representative

Umberto Malapelle

Chair of Predictive Molecular Pathology Laboratory, Department of Public Health, University of Naples Federico II

Executive Team

The Executive Committee is responsible for the supervision of the Executive Director and the day-to-day strategic management of the program. With their knowledge and know-how, the Executive Committee provides valuable support for the Executive Director in day-to-day operations and decision-making. The role of the Executive Committee member is voluntary and is not compensated for.